pharma news today glp-1 obesity drug π The next trillion-dollar war has begun Drugmakers including Eli Lilly, Novo Nordisk, Pfizer, Amgen, AstraZeneca and others are racing beyond today's drugs. New pills, monthly injections and next-generation Obesity drugs have displaced oncology
Description
Improving quality of diabetes care by integrating psychological and social care for poorly controlled diabetes: 3 dimensions of care for diabetes
In addiction treatment settings specifically, patients have generally tolerated the medications well, and clinicians have reported no unexpected or severe adverse effects
Otherwise process has been easy
The present study is the first to compare SGLT2is and GLP-1 RAs through a common comparator (placebo/metformin) for PCOS
